Extracorporeal CO2 removal and O2 transfer: A review of the concept, improvements and future development

Since the 70s, the extracorporeal carbon dioxide removal concept played a role in adjusting respiratory
acidosis associated with Tidal Volume reduction in protective ventilation settings.
Kolobow and Gattinoni in 1977 were the first in introducing extracorporeal support, with the intent to
separate carbon dioxide removal from oxygen uptake: carbon dioxide was removed by a pump-driven
modified ECMO with veno-venous bypass, while oxygenation was accomplished by high levels of PEEP,
applying only a few ventilator breaths at low volumes and low peak inspiratory pressures (“lung rest”) to
prevent damage of the compromised lungs.
Nevertheless extracorporeal support was restricted to controlled clinical trials because of the high
incidence of serious complications like hemorrhage, hemolysis and neurological impairments.
Technological improvement led to the implementation of different devices less invasive for the patient
and less complex for clinician (however unable to transfer oxygen): the interventional Lung Assist (iLA)
and the Veno-venous ECCO2R, which brought back attention to the CO2 removal concept.
Is foreseeable the future development of more efficient devices capable of removing a substantial
amount of carbon dioxide allowing a more protective ventilation. This would embody the modern
mechanical ventilation philosophy: avoid tracheal tubes, minimize sedation, prevent VILI and hospital
acquired infections.